Abivax Sa American Stock Price Prediction
| ABVX Stock | 145.31 6.96 5.03% |
Momentum 66
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.92) | EPS Estimate Current Year (3.41) | EPS Estimate Next Year (2.92) | Wall Street Target Price 123.7778 | EPS Estimate Current Quarter (0.95) |
Using Abivax SA hype-based prediction, you can estimate the value of Abivax SA American from the perspective of Abivax SA response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Abivax SA using Abivax SA's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Abivax using crowd psychology based on the activity and movement of Abivax SA's stock price.
Abivax SA Short Interest
An investor who is long Abivax SA may also wish to track short interest. As short interest increases, investors should be becoming more worried about Abivax SA and may potentially protect profits, hedge Abivax SA with its derivative instruments, or be ready for some potential downside.
200 Day MA 37.8314 | Short Percent 0.0261 | Short Ratio 1.56 | Shares Short Prior Month 1.8 M | 50 Day MA 90.9643 |
Abivax SA American Hype to Price Pattern
Investor biases related to Abivax SA's public news can be used to forecast risks associated with an investment in Abivax. The trend in average sentiment can be used to explain how an investor holding Abivax can time the market purely based on public headlines and social activities around Abivax SA American. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Abivax SA's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Abivax SA.
Abivax SA Implied Volatility | 1.15 |
Abivax SA's implied volatility exposes the market's sentiment of Abivax SA American stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abivax SA's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abivax SA stock will not fluctuate a lot when Abivax SA's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Abivax SA to buy its stock at a price that has no basis in reality. In that case, they are not buying Abivax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Abivax SA after-hype prediction price | USD 149.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Abivax contract
Based on the Rule 16, the options market is currently suggesting that Abivax SA American will have an average daily up or down price movement of about 0.0719% per day over the life of the 2026-02-20 option contract. With Abivax SA trading at USD 145.31, that is roughly USD 0.1 . If you think that the market is fully incorporating Abivax SA's daily price movement you should consider acquiring Abivax SA American options at the current volatility level of 1.15%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Abivax SA Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abivax SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abivax SA After-Hype Price Prediction Density Analysis
As far as predicting the price of Abivax SA at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Abivax SA or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Abivax SA, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Abivax SA Estimiated After-Hype Price Volatility
In the context of predicting Abivax SA's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Abivax SA's historical news coverage. Abivax SA's after-hype downside and upside margins for the prediction period are 130.78 and 153.75, respectively. We have considered Abivax SA's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Abivax SA is very steady at this time. Analysis and calculation of next after-hype price of Abivax SA American is based on 3 months time horizon.
Abivax SA Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Abivax SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abivax SA backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Abivax SA, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.98 | 4.22 | 4.66 | 0.69 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
145.31 | 149.59 | 2.95 |
|
Abivax SA Hype Timeline
Abivax SA American is presently traded for 145.31. The entity has historical hype elasticity of 4.66, and average elasticity to hype of competition of -0.69. Abivax is anticipated to increase in value after the next headline, with the price projected to jump to 149.59 or above. The average volatility of media hype impact on the company the price is about 88.66%. The price jump on the next news is projected to be 2.95%, whereas the daily expected return is presently at 0.98%. The volatility of related hype on Abivax SA is about 600.0%, with the expected price after the next announcement by competition of 144.62. Abivax SA American currently holds 97.36 M in liabilities. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out Abivax SA Basic Forecasting Models to cross-verify your projections.Abivax SA Related Hype Analysis
Having access to credible news sources related to Abivax SA's direct competition is more important than ever and may enhance your ability to predict Abivax SA's future price movements. Getting to know how Abivax SA's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Abivax SA may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RYTM | Rhythm Pharmaceuticals | 2.93 | 10 per month | 2.50 | 0.06 | 4.03 | (4.25) | 15.72 | |
| MRUS | Merus BV | 0.07 | 8 per month | 0.00 | 0.12 | 0.51 | (0.23) | 36.44 | |
| CYTK | Cytokinetics | (1.75) | 9 per month | 2.40 | 0.13 | 5.37 | (3.95) | 13.04 | |
| AXSM | Axsome Therapeutics | (0.21) | 7 per month | 1.32 | 0.19 | 4.03 | (2.37) | 9.56 | |
| HALO | Halozyme Therapeutics | 1.23 | 8 per month | 0.00 | (0.14) | 2.79 | (2.91) | 9.83 | |
| NUVL | Nuvalent | (3.24) | 11 per month | 2.50 | 0.13 | 4.99 | (4.66) | 15.40 | |
| JAZZ | Jazz Pharmaceuticals PLC | 1.07 | 9 per month | 1.20 | 0.12 | 3.66 | (2.50) | 24.53 | |
| CORT | Corcept Therapeutics Incorporated | 1.66 | 9 per month | 3.82 | 0.01 | 4.15 | (4.14) | 20.45 | |
| MDGL | Madrigal Pharmaceuticals | (8.09) | 10 per month | 1.44 | 0.16 | 7.29 | (2.65) | 12.14 |
Abivax SA Additional Predictive Modules
Most predictive techniques to examine Abivax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Abivax using various technical indicators. When you analyze Abivax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Abivax SA Predictive Indicators
The successful prediction of Abivax SA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Abivax SA American, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Abivax SA based on analysis of Abivax SA hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Abivax SA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Abivax SA's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Company Equity Multiplier | 10.2 | 1.67 | 5.06 | 5.31 | Effective Tax Rate | 0.0686 | 0.0295 | 0.0364 | 0.0345 |
Story Coverage note for Abivax SA
The number of cover stories for Abivax SA depends on current market conditions and Abivax SA's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Abivax SA is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Abivax SA's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Abivax SA Short Properties
Abivax SA's future price predictability will typically decrease when Abivax SA's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Abivax SA American often depends not only on the future outlook of the potential Abivax SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abivax SA's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 63 M | |
| Cash And Short Term Investments | 144.2 M |
Additional Tools for Abivax Stock Analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.